Beginning in January, commercialization of Pfizer’s Paxlovid antiviral medication will begin and could drive out-of-pocket prices north of $500 before insurance, according to CNN.
Read the full post on Becker's Hospital Review - Healthcare News
HHS, Pfizer begin commercialization plans for Paxlovid
